KR-39038 is an orally active GRK5 (G protein-coupled receptor kinase 5) inhibitor (IC50: 0.02 µM) that inhibits the HDAC5 pathway in neonatal cardiomyocytes and significantly reduces angiotensin II-induced hypertrophy, leading to notable anti-myocardial hypertrophy effects and improved cardiac function. KR-39038 is applicable for heart failure research.
Molecular Weight:
475
CAS Number:
[2770300-35-9]
Formula:
C24H32ClFN6O
Target:
Others|||HDAC|||GRK
T64266
* VAT and and shipping costs not included. Errors and price changes excepted
